Phibro Animal Health (NASDAQ:PAHC) Releases FY 2024 Earnings Guidance

Phibro Animal Health (NASDAQ:PAHCGet Free Report) updated its FY 2024 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 1.040-1.160 for the period, compared to the consensus estimate of 1.100. The company issued revenue guidance of $980.0 million-$1.0 billion, compared to the consensus revenue estimate of $999.0 million.

Phibro Animal Health Price Performance

NASDAQ:PAHC traded up $0.41 during trading hours on Wednesday, reaching $17.18. 130,110 shares of the company’s stock were exchanged, compared to its average volume of 152,202. The company has a market capitalization of $695.79 million, a P/E ratio of 47.72, a price-to-earnings-growth ratio of 6.30 and a beta of 0.63. Phibro Animal Health has a 12 month low of $9.40 and a 12 month high of $17.44. The business’s 50-day simple moving average is $13.39 and its two-hundred day simple moving average is $12.00. The company has a quick ratio of 1.60, a current ratio of 3.12 and a debt-to-equity ratio of 1.66.

Phibro Animal Health (NASDAQ:PAHCGet Free Report) last released its quarterly earnings data on Wednesday, February 7th. The company reported $0.33 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.06. The business had revenue of $249.90 million during the quarter, compared to analyst estimates of $242.91 million. Phibro Animal Health had a return on equity of 16.67% and a net margin of 1.51%. Sell-side analysts expect that Phibro Animal Health will post 1.12 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, StockNews.com upgraded Phibro Animal Health from a hold rating to a buy rating in a report on Tuesday, April 9th.

Read Our Latest Stock Analysis on PAHC

About Phibro Animal Health

(Get Free Report)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

Featured Stories

Earnings History and Estimates for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.